TG Therapeutics Inc. (TGTX) |
|
7.74 -0.23 (-2.89%)
|
07-19 16:00 |
|
Open: |
7.97 |
Pre. Close: |
7.97 |
|
High:
|
7.98 |
Low:
|
7.74 |
|
Volume:
|
972,367 |
Market Cap:
|
703M |
|
|
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
8.003 - 8.047 |
8.047 - 8.083 |
|
Low:
|
7.604 - 7.666 |
7.666 - 7.717 |
|
Close:
|
7.649 - 7.741 |
7.741 - 7.816 |
|
Technical analysis |
as of: 2019-07-22 12:42:05 AM |
|
Overall:
|
  |
| Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected. |
| Target: |
Six months: 9.81 One year: 10.96 |
| Support: |
Support1: 6.81 Support2: 5.67 |
| Resistance: |
Resistance1: 8.40 Resistance2: 9.38 |
| Pivot: |
8.26 |
| Moving Average: |
MA(5): 7.86 MA(20): 7.99 
MA(100): 7.51 MA(250): 7.09 |
| MACD: |
MACD(12,26): 0.11 Signal(9): 0.19 |
| Stochastic oscillator: |
%K(14,3): 26.48 %D(3): 35.57 |
| RSI: |
RSI(14): 48.01 |
| 52-week: |
High: 12.90 Low: 3.32 Change(%): -36.3 |
| Average Vol(K): |
3-Month: 151730 10-Days: 114140 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.TGTX has closed above bottom band by 18.2%. Bollinger Bands are 10.7% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Headline News |
Mon, 01 Jul 2019 21:34:20 Z
7 Stocks on Sale the Insiders Are Buying
Fri, 28 Jun 2019 16:09:20 Z
Friday 6/28 Insider Buying Report: BSTZ, TGTX
Thu, 27 Jun 2019 21:07:50 Z
Thursday's ETF Movers: XBI, XLE
Fri, 10 May 2019 20:13:50 Z
Health Care Sector Update for 05/10/2019: JNJ, PFE, ABT, MRK, AMGN, GENE, PIRS, TGTX
Fri, 10 May 2019 17:58:16 Z
TG Therapeutics Inc (TGTX) Q1 2019 Earnings Call Transcript
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
 |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
|
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
|
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Sector: Healthcare |
| Industry: Biotechnology |
| Shares Out. (M) |
90.84 |
| Shares Float (M) |
55.67 |
|
% Held by Insiders
|
11.16 |
|
% Held by Institutions
|
68.87 |
|
Shares Short (K)
|
13550 |
|
Shares Short P. Month (K)
|
|
Stock Financials |
|
EPS
|
-2.140 |
|
EPS Est. Current Year
|
-1.840 |
|
EPS Est. Next Year
|
-1.640 |
|
EPS Est. Next Quarter
|
-0.450 |
|
Forward EPS
|
-1.960 |
|
Book Value (p.s.)
|
0.230 |
|
PEG Ratio
|
|
|
Profit Margin
|
|
|
Operating Margin
|
-110205.26 |
|
Return on Assets (ttm)
|
-87.8 |
|
Return on Equity (ttm)
|
-319.9 |
|
Qtrly Rev. Growth
|
|
|
Gross Profit (p.s.)
|
0.002 |
|
Sales Per Share
|
|
|
EBITDA (p.s.)
|
-1.843 |
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
-134.23 |
|
Levered Free Cash Flow (M)
|
-71.45 |
Stock Valuations |
|
P/E
|
-3.62 |
|
P/E Growth Ratio
|
-0.03 |
|
P/BV
|
33.65 |
|
P/S
|
|
|
P/CF
|
-5.24 |
Dividends & Splits |
|
Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Forward Dividend
|
|
|
Last Split Date
|
2012-04-30 |
|
Last Split Ratio
|
-1e+010 |
|
7 Binary Options
|
|
Your Ad Here
|
|
